Obermatt
See Similar Stocks →

Cronos Group

TOR:CRON · CA22717L1013
PharmaceuticalsSmall

360

45
Profit price1
Owner Earnings Yield34
Dividend Yield1
Price/Sales19
EV / Gross Profit72
Price/Book58
Return on Capital33
Cash Return on Capital33
Return on Equity40
EBIT Margin11
Gross Profitability17
Accruals71
Owner Earnings Margin28
Sales growth83
Profit Growth5
Owner Earnings Growth16
Reinvestment14
Price momentum59
Debt load92
Refinancing62
Debt Payback100
Liquidity1
Analyst ratings52
Opinion Changes50
Price Target Upside16
Market mood3
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Cronos Group generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryCanada
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeTSX
Employees299
Websitethecronosgroup.com
ISINCA22717L1013
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
CannabisAlternative Medicine

Description

Cronos Group Inc. (Cronos) is a global cannabinoid company. The company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer…

Analysis

Middle-of-the-road

Cronos Group Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 2580.4×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is sturdy. The company scores 14/20 on our value-creation score: strong value creator.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
52
2023202420252026

All-time high

59

Jan 2024

All-time low

29

Jan 2023

Average rank

45

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
19
22
14
12
Price/Earnings
43
1
9
9
Price/Book
58
71
64
74
Dividend Yield
1
1
1
1
Value (overall)
18
14
32
39

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Cronos Group with its peers
Curaleaf Holdings
TOR:CURA
14
CountryUSA
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
OrganiGram Holdings
TOR:OGI
39
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Canopy Growth
TOR:WEED
19
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Cresco Labs
CNX:CL
43
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Trulieve Cannabis
CNX:TRUL
39
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
High Tide
CVE:HITI
62
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →